Bessemer Group Inc. lowered its stake in Haleon plc (NYSE:HLN – Free Report) by 11.4% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 16,321 shares of the company’s stock after selling 2,093 shares during the quarter. Bessemer Group Inc.’s holdings in Haleon were worth $134,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of HLN. Ironwood Wealth Management LLC. purchased a new stake in Haleon in the 3rd quarter worth $70,000. Tower Research Capital LLC TRC purchased a new stake in shares of Haleon during the 3rd quarter valued at about $115,000. Credit Suisse AG purchased a new stake in shares of Haleon during the 3rd quarter valued at about $76,000. Guggenheim Capital LLC purchased a new stake in shares of Haleon during the 3rd quarter valued at about $119,000. Finally, BlackRock Inc. purchased a new stake in shares of Haleon during the 3rd quarter valued at about $10,366,000. Hedge funds and other institutional investors own 6.67% of the company’s stock.
Analyst Ratings Changes
HLN has been the topic of several recent research reports. Stifel Nicolaus initiated coverage on shares of Haleon in a research report on Wednesday, May 24th. They set a “hold” rating on the stock. Investec upgraded shares of Haleon from a “sell” rating to a “hold” rating in a research report on Tuesday, August 8th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $364.00.
Haleon Price Performance
Shares of NYSE:HLN opened at $8.26 on Friday. Haleon plc has a 12 month low of $5.59 and a 12 month high of $9.05. The firm’s 50-day moving average is $8.41 and its 200 day moving average is $8.36. The company has a current ratio of 0.84, a quick ratio of 0.54 and a debt-to-equity ratio of 0.53.
Haleon (NYSE:HLN – Get Free Report) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported $0.08 EPS for the quarter. The firm had revenue of $3.44 billion for the quarter. As a group, sell-side analysts expect that Haleon plc will post 0.45 earnings per share for the current fiscal year.
Haleon Cuts Dividend
The company also recently declared a — dividend, which will be paid on Thursday, October 5th. Investors of record on Friday, August 25th will be issued a dividend of $0.046 per share. The ex-dividend date of this dividend is Thursday, August 24th. This represents a yield of 1.3%.
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.
Featured Stories
- Five stocks we like better than Haleon
- What is a Low P/E Ratio and What Does it Tell Investors?
- One of these 5 Pet Care Stocks Can Be the Next Short Squeeze
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 3 High Short Interest Stocks that Investors are Getting Wrong
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Retail Theft Rises: Two Ways For Investors To Beat Shrinkage
Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLN – Free Report).
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
